V. Hornung, J. Ellegast, S. Kim, K. Brzozka, and A. Jung, 5'-Triphosphate RNA Is the Ligand for RIG-I, Science, vol.314, issue.5801, pp.994-997, 2006.
DOI : 10.1126/science.1132505

E. Meylan, J. Curran, K. Hofmann, D. Moradpour, and M. Binder, Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus, Nature, vol.69, issue.7062, pp.1167-1172, 2005.
DOI : 10.1016/j.cell.2005.08.012

M. Gack, Y. Shin, C. Joo, T. Urano, and C. Liang, TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity, Nature, vol.7, issue.7138, pp.916-920, 2007.
DOI : 10.1038/nature05732

M. Yoneyama and T. Fujita, RNA recognition and signal transduction by RIG-I-like receptors, Immunological Reviews, vol.282, issue.1, pp.54-65, 2009.
DOI : 10.1111/j.1600-065X.2008.00727.x

R. Sumpter, J. Loo, Y. Foy, E. Li, K. Yoneyama et al., Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I, Journal of Virology, vol.79, issue.5, pp.2689-2699, 2005.
DOI : 10.1128/JVI.79.5.2689-2699.2005

T. Saito, D. Owen, F. Jiang, J. Marcotrigiano, M. Gale et al., Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA, Nature, vol.448, issue.7203, pp.523-527, 2008.
DOI : 10.1038/nature07106

Y. Loo, D. Owen, K. Li, A. Erickson, and C. Johnson, Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.103, issue.15, pp.6001-6006, 2006.
DOI : 10.1073/pnas.0601523103

D. Lau, P. Fish, M. Sinha, D. Owen, and S. Lemon, Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients, Hepatology, vol.192, issue.Suppl, pp.799-809, 2008.
DOI : 10.1002/hep.22076

G. Cheng, J. Zhong, and F. Chisari, Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms, Proceedings of the National Academy of Sciences, vol.103, issue.22, pp.8499-8504, 2006.
DOI : 10.1073/pnas.0602957103

A. Sadler and B. Williams, Structure and Function of the Protein Kinase R, Curr Top Microbiol Immunol, vol.316, pp.253-292, 2007.
DOI : 10.1007/978-3-540-71329-6_13

K. Blight, J. Mckeating, and C. Rice, Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication, Journal of Virology, vol.76, issue.24, pp.13001-13014, 2002.
DOI : 10.1128/JVI.76.24.13001-13014.2002

D. Akazawa, T. Date, K. Morikawa, A. Murayama, and M. Miyamoto, CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection, Journal of Virology, vol.81, issue.10, pp.5036-5045, 2007.
DOI : 10.1128/JVI.01573-06

M. Garcia, E. Meurs, and E. M. , The dsRNA protein kinase PKR: Virus and cell control, Biochimie, vol.89, issue.6-7, pp.799-811, 2007.
DOI : 10.1016/j.biochi.2007.03.001

I. Terenin, S. Dmitriev, D. Andreev, and I. Shatsky, Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2, Nature Structural & Molecular Biology, vol.250, issue.8, pp.836-841, 2008.
DOI : 10.1128/MCB.02138-06

L. Balvay, R. Rifo, E. Ricci, D. Decimo, and T. Ohlmann, Structural and functional diversity of viral IRESes, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1789, issue.9-10, pp.542-547, 2009.
DOI : 10.1016/j.bbagrm.2009.07.005

J. Hugon, C. Paquet, and R. Chang, Could PKR inhibition modulate human neurodegeneration?, Expert Review of Neurotherapeutics, vol.9, issue.10, pp.1455-1457, 2009.
DOI : 10.1586/ern.09.92

N. Jammi, L. Whitby, and P. Beal, Small molecule inhibitors of the RNA-dependent protein kinase, Biochemical and Biophysical Research Communications, vol.308, issue.1, pp.50-57, 2003.
DOI : 10.1016/S0006-291X(03)01318-4

S. Nekhai, D. Bottaro, G. Woldehawariat, A. Spellerberg, and R. Petryshyn, A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation, Peptides, vol.21, issue.10, pp.1449-1456, 2000.
DOI : 10.1016/S0196-9781(00)00297-7

U. Garaigorta and F. Chisari, Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation, Cell Host & Microbe, vol.6, issue.6, pp.513-522, 2009.
DOI : 10.1016/j.chom.2009.11.004

L. Saunders and G. Barber, The dsRNA binding protein family: critical roles, diverse cellular functions, The FASEB Journal, vol.17, issue.9, pp.961-983, 2003.
DOI : 10.1096/fj.02-0958rev

A. Dar, T. Dever, and F. Sicheri, Higher-Order Substrate Recognition of eIF2?? by the RNA-Dependent Protein Kinase PKR, Cell, vol.122, issue.6, pp.887-900, 2005.
DOI : 10.1016/j.cell.2005.06.044

L. Manche, S. Green, C. Schmedt, and M. Mathews, Interactions between double-stranded RNA regulators and the protein kinase DAI., Molecular and Cellular Biology, vol.12, issue.11, pp.5238-5248, 1992.
DOI : 10.1128/MCB.12.11.5238

S. Nallagatla, J. Hwang, R. Toroney, X. Zheng, and C. Cameron, 5'-Triphosphate-Dependent Activation of PKR by RNAs with Short Stem-Loops, Science, vol.318, issue.5855, pp.1455-1458, 2007.
DOI : 10.1126/science.1147347

A. Daher, G. Laraki, M. Singh, C. Melendez-pena, and S. Bannwarth, TRBP Control of PACT-Induced Phosphorylation of Protein Kinase R Is Reversed by Stress, Molecular and Cellular Biology, vol.29, issue.1, pp.254-265, 2009.
DOI : 10.1128/MCB.01030-08

URL : https://hal.archives-ouvertes.fr/pasteur-00460560

M. Binder, G. Kochs, R. Bartenschlager, and V. Lohmann, Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy, Hepatology, vol.314, issue.5, pp.1365-1374, 2007.
DOI : 10.1002/hep.21829

T. Shimoike, S. Mckenna, D. Lindhout, and J. Puglisi, Translational insensitivity to potent activation of PKR by HCV IRES RNA, Antiviral Research, vol.83, issue.3, pp.228-237, 2009.
DOI : 10.1016/j.antiviral.2009.05.004

C. Wang, J. Pflugheber, R. Sumpter, J. Sodora, D. Hui et al., Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication, Journal of Virology, vol.77, issue.7, pp.3898-3912, 2003.
DOI : 10.1128/JVI.77.7.3898-3912.2003

J. Kang, S. Kwon, S. Park, Y. Kim, and S. Choi, PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control, Virus Research, vol.142, issue.1-2, pp.51-56, 2009.
DOI : 10.1016/j.virusres.2009.01.007

X. Yan, S. Battaglia, D. Boucreux, Z. Chen, and C. Brechot, Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR, Virus Research, vol.125, issue.1, pp.79-87, 2007.
DOI : 10.1016/j.virusres.2006.12.010

M. Brocard, S. Paulous, A. Komarova, V. Deveaux, and K. Kean, Evidence that PTB does not stimulate HCV IRES-driven translation, Virus Genes, vol.14, issue.6, pp.5-15, 2007.
DOI : 10.1007/s11262-006-0038-z

M. Dreux, P. Gastaminza, S. Wieland, and F. Chisari, The autophagy machinery is required to initiate hepatitis C virus replication, Proceedings of the National Academy of Sciences, vol.106, issue.33, pp.14046-14051, 2009.
DOI : 10.1073/pnas.0907344106

J. Langland, J. Cameron, M. Heck, J. Jancovich, and B. Jacobs, Inhibition of PKR by RNA and DNA viruses, Virus Research, vol.119, issue.1, pp.100-110, 2006.
DOI : 10.1016/j.virusres.2005.10.014

M. Gale, J. Blakely, C. Kwieciszewski, B. Tan, S. Dossett et al., Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation, Molecular and Cellular Biology, vol.18, issue.9, pp.5208-5218, 1998.
DOI : 10.1128/MCB.18.9.5208

D. Taylor, S. Shi, P. Romano, G. Barber, and M. Lai, Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein, Science, vol.285, issue.5424, pp.107-110, 1999.
DOI : 10.1126/science.285.5424.107

N. Pavio, D. Taylor, and M. Lai, Detection of a Novel Unglycosylated Form of Hepatitis C Virus E2 Envelope Protein That Is Located in the Cytosol and Interacts with PKR, Journal of Virology, vol.76, issue.3, pp.1265-1272, 2002.
DOI : 10.1128/JVI.76.3.1265-1272.2002

R. Sumpter, J. Wang, C. Foy, E. Loo, Y. Gale et al., Viral Evolution and Interferon Resistance of Hepatitis C Virus RNA Replication in a Cell Culture Model, Journal of Virology, vol.78, issue.21, pp.11591-11604, 2004.
DOI : 10.1128/JVI.78.21.11591-11604.2004

E. Hinson and P. Cresswell, The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic ??-helix, Proceedings of the National Academy of Sciences, vol.106, issue.48, pp.20452-20547, 2009.
DOI : 10.1073/pnas.0911679106

L. Strahle, J. Marq, A. Brini, S. Hausmann, and D. Kolakofsky, Activation of the Beta Interferon Promoter by Unnatural Sendai Virus Infection Requires RIG-I and Is Inhibited by Viral C Proteins, Journal of Virology, vol.81, issue.22, pp.12227-12237, 2007.
DOI : 10.1128/JVI.01300-07

K. Kalliampakou, M. Kalamvoki, and P. Mavromara, Hepatitis C virus (HCV) NS5A protein downregulates HCV IRES-dependent translation, Journal of General Virology, vol.86, issue.4, pp.1015-1025, 2005.
DOI : 10.1099/vir.0.80728-0

A. Breiman, N. Grandvaux, R. Lin, C. Ottone, and S. Akira, Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway during Hepatitis C Virus Expression and Restoration of Signaling by IKK??, Journal of Virology, vol.79, issue.7, pp.3969-3978, 2005.
DOI : 10.1128/JVI.79.7.3969-3978.2005

R. Lin, J. Lacoste, P. Nakhaei, Q. Sun, and L. Yang, Dissociation of a MAVS/IPS-1/VISA/Cardif-IKK?? Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage, Journal of Virology, vol.80, issue.12, pp.6072-6083, 2006.
DOI : 10.1128/JVI.02495-05

A. Laurent, B. Krust, J. Galabru, J. Svab, and A. Hovanessian, Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells., Proceedings of the National Academy of Sciences, vol.82, issue.13, pp.4341-4345, 1985.
DOI : 10.1073/pnas.82.13.4341